Cargando…
Genome, Metabolism, or Immunity: Which Is the Primary Decider of Pancreatic Cancer Fate through Non-Apoptotic Cell Death?
Pancreatic ductal adenocarcinoma (PDAC) is a solid tumor characterized by poor prognosis and resistance to treatment. Resistance to apoptosis, a cell death process, and anti-apoptotic mechanisms, are some of the hallmarks of cancer. Exploring non-apoptotic cell death mechanisms provides an opportuni...
Autores principales: | Barar, Erfaneh, Shi, Jiaqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603981/ https://www.ncbi.nlm.nih.gov/pubmed/37893166 http://dx.doi.org/10.3390/biomedicines11102792 |
Ejemplares similares
-
Is aneuploidy deciding your fate?
por: Rowald, Konstantina, et al.
Publicado: (2014) -
Which Model Is Best? Let the Data Decide
Publicado: (1999) -
Dynamics of p53: A Master Decider of Cell Fate
por: Luo, Qingyin, et al.
Publicado: (2017) -
To senesce or not to senesce: how primary human fibroblasts decide their cell fate after DNA damage
por: Kollarovic, Gabriel, et al.
Publicado: (2016) -
Deciding the fate of disputed embryos: ethical issues in the case of Natallie Evans
por: Smajdor, Anna
Publicado: (2007)